The low molecular weight Dextran 40 inhibits the adhesion of T lymphocytes to endothelial cells

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 422-426

  Termeer, C C ^a   Weiss, J M ^a   Schopf E ^a   Vanscheidt, W ^a   Simon, J C ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Department of Dermatology ^*  (Germany)

Author keywords

Adhesion assay; Endothelical cells; T cells

Indexed keywords

BETA1 INTEGRIN; CD11 ANTIGEN; CD18 ANTIGEN; DEXTRAN 40; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BLOOD RHEOLOGY; CELL ADHESION; DRUG EFFECT; ENDOTHELIUM CELL; LYMPHOMA CELL LINE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; DEXTRANS; ENDOTHELIUM, VASCULAR; INTEGRIN ALPHA4BETA1; INTEGRINS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MOLECULAR WEIGHT; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031736310     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00729.x     Document Type: Article

References (21)

1. Mishler JM. Synthetic plasma volume expanders - their pharmacology, safety and clinical efficiency. Clin Haematol 1984; 13:75-92.
2. Klotz U, Kroemer H. Clinical pharmacokinetic considerations in the use of plasma expanders. Clin Pharmacokin 1987; 12:123-35.
3. Schwarz JA, Koch W, Bühler V, Kaumeier K. Pharmacokineties of low molecular dextran (Dx1) in volunteers. Int J Clin Pharmacol 1981; 19:358-67.
4. Rein MS, Hill JA. 32% Dextran 70 (Hyskon) inhibits lymphocyte and macrophage function in vitro: a potential new mechanism for adhesion prevention. Fertil Steril 1989; 52:953-7.
5. Gabaldon M, Zuniga A, Capdevila C, Marques A. Effect of hyperlipidemic diets, proinflammatory agents and plasma expanders on leukocyte adhesion to the endothelium of aorta and carotid artery of rats. Artherosclerosis 1994; 110:209-23.
6. Ohkuho C, Bigos D, Jain RK. IL-2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. Cancer Res 1991; 51:1561-3.
7. Menger DM, Thierjung C, Hammersen F, Messmer K. Dextran versus Hydroxyethylstarch in inhibition of posteschemic leukocyte adherence in striated muscle. Circ Shock 1993; 41:248-55.
8. Springer T. Traffic signals for lymphocyte recirculation and leukocyte emigration; the multistep paradigm. Cell 1994; 76:301-14.
9. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992; 13:106-12.
10. Hahne M, Jäger U, Isenmann S, Hallmann R, Vestweber D. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 1993; 121:655-64.
11. Takei F. Inhibition of mixed lymphocyte responses by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 1985; 134:1403-7.
12. Williams RL, Courtneidge SA, Wagner EF. Embryonic lethalities and endotheliomal tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 1988; 52:121-31.
13. Halzmann B, Weissmann IL. Peyer's patch-specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel. EMBO J 1988; 8:1735-41.
14. Weiss JM, Vanscheidt W, Pilarski KA, Weyl A, Peschen M, Schöpf E, Vestweber D, Simon JC. Pentoxifylline inhibits tumor necrosis factor alpha induced T-lymphoma cell adhesion to endothelioma cells. J Invest Dermatol 1995; 104:1-5.
15. Weiss JM, Pilarski K, Weyl A, Peschen M, Schöpf E, Vestweber D, Vanscheidt W, Simon JC. Prostaglandin E1 inhibits TNFα-induced T cell adhesion to endothelial cells by selective down-modulation of ICAM-1 expression on endothelial cells. Exp Dermatol 1995; 4:302-7.
16. Termeer CC, Weiss JM, Dittmar H, Vanscheidt W, Schöpf E, Simon JC. Determination of T-lymphocyte adhesion to endothelial cells using a novel luminescence marker. Immunotechnology 1998; 3:245-52.
17. Rosenman SJ, Ganji AA, Teder TF, Gallatin WM. Syn-capping of human T-lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells. J Leuko Biol 1993; 53:1-10.
18. 2+ modulates leukocyte function-associated-antigen-1 cell surface distribution on T-lymphocytes and consequently affects cell adhesion. J Cell Biol 1994; 126:1061-70.
19. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84:345-57.
20. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 1994; 4:506-17.
21. Sanchez-Mateos P, Campanero MR, Balboa MA, Sanchez-Madrid F. Co-clustering of β1 integrins, cytoskeletal proteins, and tyrosine-phosphorylated substrates during integrin-mediated leukocyte aggregation. J Immunol 1993; 151:3817-28.